Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Bluejay Diagnostics has closed an $8.5 million private placement priced at-the-market on Nasdaq, with potential to raise an additional $15.2 million through warrant exercises. The proceeds are expected to extend the company's cash runway into Q1 2027, supporting FDA submission and subsequent commercialization of its near-patient sepsis testing prod…